CD44 and cancer: E-selectin recognizes sialylated carbohydrates/fucosylated glycoprotein ligands such as ESL-1, PSGL-1, CD44 and CLA, among others (Table 1), that are expressed on circulating leukocytes and overexpressed on cancer cells.